CLINICAL_TRIALS
trial_result
· 2013-08-23
Clinical Trial Update: VivaGel™ in Healthy Young Women [Phase 1]
Summary
A Phase 1 clinical trial of VivaGel in healthy young women to assess safety/tolerability for preventing HSV-2 infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex II | Phase 1 | Status: COMPLETED